Longitudinal assessment of regional directed delivery in a rodent malignant glioma model: Laboratory investigation

Journal of Neurosurgery: Pediatrics

Volumn 4, Issue 6, 2009, Pages 592-598

  Kondo, Akihide ^a,b   Goldman, Stewart ^a   Lulla, Rishi R ^a,b   Mania Farnell, Barbara ^c   Vanin, Elio F ^b   Sredni, Simone T ^b   Rajaram, Veena ^a   Soares, Marcelo B ^b   Tomita, Tadanori ^a  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c PURDUE UNIVERSITY CALUMET   (United States)

Author keywords

Bioluminescence imaging; Carboplatin; Chemotherapy; Convection enhanced delivery; Rat glioma model

Indexed keywords

CARBOPLATIN; LUCIFERASE; RETROVIRUS VECTOR; ANTINEOPLASTIC AGENT; DIAGNOSTIC AGENT; LUMINESCENT AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLUMINESCENCE; BRAIN TUMOR; CANCER CHEMOTHERAPY; CONTROLLED STUDY; CONVECTION ENHANCED DELIVERY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; GLIOMA; GLIOSARCOMA; HISTOPATHOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SURVIVAL TIME; TREATMENT RESPONSE; TUMOR CELL; TUMOR RECURRENCE; TUMOR VOLUME; ANIMAL; METHODOLOGY; PATHOLOGY; SURVIVAL; TIME; TREATMENT OUTCOME; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CARBOPLATIN; CELL LINE, TUMOR; DRUG DELIVERY SYSTEMS; GLIOSARCOMA; LUCIFERASES; LUMINESCENT AGENTS; MALE; RATS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 73349099071     PISSN: 19330707     EISSN: 19330715     Source Type: Journal    
DOI: 10.3171/2009.7.PEDS09186     Document Type: Article

References (35)

1. Adams SB Jr, Herz PR, Stamper DL, Roberts MJ, Bourquin S, Patel NA, et al: High-resolution imaging of progressive articular cartilage degeneration. J Orthop Res 24:708-715, 2006
2. Aoki T, Takahashi JA, Ueba T, Oya N, Hiraoka M, Matsui K, et al: Phase II study of nimustine, carboplatin, vincristine, and interferon-beta with radiotherapy for glioblastoma multiforme: experience of the Kyoto Neuro-Oncology Group. J Neurosurg 105:385-391, 2006
3. Barth RF: Rat brain tumor models in experimental neurooncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas. J Neurooncol 36:91-102, 1998
4. Bobo RH, Laske DW, Akbasak A, Morrison PF, Dedrick RL, Oldfield EH: Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci U S A 91:2076-2080, 1994
5. Broaddus WC, Prabhu SS, Gillies GT, Neal J, Conrad WS, Chen ZJ, et al: Distribution and stability of antisense phosphorothioate oligonucleotides in rodent brain following direct intraparenchymal controlled-rate infusion. Neurosurg Focus 3(5):Article 4, 1997
6. Bryant MJ, Chuah TL, Luff J, Lavin MF, Walker DG: A novel rat model for glioblastoma multiforme using a bioluminescent F98 cell line. J Clin Neurosci 15:545-551, 2008
7. Carson BS Sr, Wu Q, Tyler B, Sukay L, Raychaudhuri R, Di-Meco F, et al: New approach to tumor therapy for inoperable areas of the brain: chronic intraparenchymal drug delivery. J Neurooncol 60:151-158, 2002
8. Degen JW, Walbridge S, Vortmeyer AO, Oldfield EH, Lonser RR: Safety and efficacy of convection-enhanced delivery of gemcitabine or carboplatin in a malignant glioma model in rats. J Neurosurg 99:893-898, 2003
9. Dinca EB, Sarkaria JN, Schroeder MA, Carlson BL, Voicu R, Gupta N, et al: Bioluminescence monitoring of intracranial glioblastoma xenograft: response to primary and salvage temozolomide therapy. J Neurosurg 107:610-616, 2007
10. Doz F, Berens ME, Dougherty DV, Rosenblum ML: Comparison of the cytotoxic activities of cisplatin and carboplatin against glioma cell lines at pharmacologically relevant drug exposures. J Neurooncol 11:27-35, 1991
11. Gallia GL, Tyler BM, Hann CL, Siu IM, Giranda VL, Vescovi AL, et al: Inhibition of Akt inhibits growth of glioblastoma and glioblastoma stem-like cells. Mol Cancer Ther 8:386-393, 2009
12. Goldberg L, Ocherashvilli A, Daniels D, Last D, Cohen ZR, Tamar G, et al: Salirasib (farnesyl thiosalicylic acid) for brain tumor treatment: a convection-enhanced drug delivery study in rats. Mol Cancer Ther 7:3609-3616, 2008
13. Groothuis DR: The blood-brain and blood-tumor barriers: a review of strategies for increasing drug delivery. Neuro Oncol 2:45-59, 2000
14. Hynynen K, Pomeroy O, Smith DN, Huber PE, McDannold NJ, Kettenbach J, et al: MR imaging-guided focused ultrasound surgery of fibroadenomas in the breast: a feasibility study. Radiology 219:176-185, 2001
15. Jacobs SS, Fox E, Dennie C, Morgan LB, McCully CL, Balis FM: Plasma and cerebrospinal fluid pharmacokinetics of intravenous oxaliplatin, cisplatin, and carboplatin in nonhuman primates. Clin Cancer Res 11:1669-1674, 2005
16. Kerbel RS, Kamen BA: The anti-angiogenic basis of metronomic chemotherapy. Nat Rev Cancer 4:423-436, 2004
17. Klerk CP, Overmeer RM, Niers TM, Versteeg HH, Richel DJ, Buckle T, et al: Validity of bioluminescence measurements for noninvasive in vivo imaging of tumor load in small animals. Biotechniques 43 (1 Suppl):7-13, 30, 2007
18. Kondo A, Goldman S, Vanin EF, Sredni ST, Rajaram V, Soares MB, et al: An experimental brainstem tumor model using in vivo bioluminescence imaging in rat. Childs Nerv Syst 25: 527-533, 2009
19. Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, et al: A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95:190-198, 2001
20. Lieberman DM, Laske DW, Morrison PF, Bankiewicz KS, Oldfield EH: Convection-enhanced distribution of large molecules in gray matter during interstitial drug infusion. J Neurosurg 82:1021-1029, 1995
21. Mardor Y, Rahav O, Zauberman Y, Lidar Z, Ocherashvilli A, Daniels D, et al: Convection-enhanced drug delivery: increased efficacy and magnetic resonance image monitoring. Cancer Res 65:6858-6863, 2005
22. Rehemtulla A, Stegman LD, Cardozo SJ, Gupta S, Hall DE, Contag CH, et al: Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. Neoplasia 2:491-495, 2000
23. Rochard E, Barthes D, Courtois P: Stability and compatibility study of carboplatin with three portable infusion pump reservoirs. Int J Pharm 101:257-262, 1994
24. Rousseau J, Boudou C, Barth RF, Balosso J, Esteve F, Elleaume H: Enhanced survival and cure of F98 glioma-bearing rats following intracerebral delivery of carboplatin in combination with photon irradiation. Clin Cancer Res 13:5195-5201, 2007
25. Rubin JB, Kung AL, Klein RS, Chan JA, Sun Y, Schmidt K, et al: A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. Proc Natl Acad Sci U S A 100:13513-13518, 2003
26. Sawyer AJ, Piepmeier JM, Saltzman WM: New methods for direct delivery of chemotherapy for treating brain tumors. Yale J Biol Med 79:141-152, 2006
27. Strege RJ, Liu YJ, Kiely A, Johnson RM, Gillis EM, Storm P, et al: Toxicity and cerebrospinal fluid levels of carboplatin chronically infused into the brainstem of a primate. J Neurooncol 67:327-334, 2004
28. Szentirmai O, Baker CH, Lin N, Szucs S, Takahashi M, Kiryu S, et al: Noninvasive bioluminescence imaging of luciferase expressing intracranial U87 xenografts: correlation with magnetic resonance imaging determined tumor volume and longitudinal use in assessing tumor growth and antiangiogenic treatment effect. Neurosurgery 58:365-372, 2006
29. Tange Y, Kondo A, Egorin MJ, Mania-Farnell B, Daneriallis GM, Nakazaki H, et al: Interstitial continuous infusion therapy in a malignant glioma model in rats. Childs Nerv Syst 25: 655-662, 2009
30. Tao-Cheng JH, Gallant PE, Brightman MW, Dosemeci A, Reese TS: Structural changes at synapses after delayed perfusion fixation in different regions of the mouse brain. J Comp Neurol 501:731-740, 2007
31. Tomita T: Interstitial chemotherapy for brain tumors: review. J Neurooncol 10:57-74, 1991
32. Vogelbaum MA: Convection enhanced delivery for the treatment of malignant gliomas: symposium review. J Neurooncol 73:57-69, 2005
33. Vogelbaum MA: Convection enhanced delivery for treating brain tumors and selected neurological disorders: symposium review. J Neurooncol 83:97-109, 2007
34. Wolff JE, Trilling T, Molenkamp G, Egeler RM, Jurgens H: Chemosensitivity of glioma cells in vitro: a meta analysis. J Cancer Res Clin Oncol 125:481-486, 1999
35. Yanagihara K, Takigahira M, Takeshita F, Komatsu T, Nishio K, Hasegawa F, et al: A photon counting technique for quantitatively evaluating progression of peritoneal tumor dissemination. Cancer Res 66:7532-7539, 2006